PIII (P3 Health Partners) EPS (Diluted) : $-49.00 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is P3 Health Partners EPS (Diluted)?

P3 Health Partners's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was $-18.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-49.00.

P3 Health Partners's EPS (Basic) for the three months ended in Dec. 2024 was $-18.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was $-45.00.

P3 Health Partners's EPS without NRI for the three months ended in Dec. 2024 was $-21.08. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 was $-56.26.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, P3 Health Partners's highest 3-Year average EPS without NRI Growth Rate was -11.10% per year. The lowest was -11.10% per year. And the median was -11.10% per year.

P3 Health Partners EPS (Diluted) Historical Data

The historical data trend for P3 Health Partners's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P3 Health Partners EPS (Diluted) Chart

P3 Health Partners Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Diluted)

Get a 7-Day Free Trial

-23.04

-325.00

-31.50

-54.00

P3 Health Partners Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EPS (Diluted)	Get a 7-Day Free Trial														-12.00	-8.00	-7.50	-15.50	-18.00

Competitive Comparison of P3 Health Partners's EPS (Diluted)

For the Medical Care Facilities subindustry, P3 Health Partners's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

P3 Health Partners's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's PE Ratio distribution charts can be found below:

* The bar in red indicates where P3 Health Partners's PE Ratio falls into.

Save Embed

;

Save Embed

;

P3 Health Partners EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

P3 Health Partners's Diluted EPS for the fiscal year that ended in Dec. 2024 is calculated as

Diluted EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-135.849	-	0)	/	2.940
	=	-46.21

P3 Health Partners's Diluted EPS for the quarter that ended in Dec. 2024 is calculated as

Diluted EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-58.617	-	0)	/	3.256
	=	-18.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-49.00

P3 Health Partners (NAS:PIII) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

P3 Health Partners EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of P3 Health Partners's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

P3 Health Partners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » P3 Health Partners Inc (NAS:PIII) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

2370 Corporate Circle, Suite 300, Henderson, NV, USA, 89074

Website

https://www.p3hp.org

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Executives

Chicago Pacific Founders Ugp Iii, Llc	10 percent owner	980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611
Atul Kavthekar	officer: Chief Financial Officer	4100 S. SAGINAW STREET, FLINT MI 48507
Sherif Abdou	director, officer: Chief Executive Officer	C/O P3 HEALTH GROUP HOLDINGS, LLC, 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074
Chicago Pacific Founders Gp Iii, L.p.	10 percent owner	980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611
Chicago Pacific Founders Ugp, Llc	10 percent owner	980 N. MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611
Leavitt Equity Partners Ii, L.p.	10 percent owner	299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111
Leavitt Legacy, Llc	10 percent owner	299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111
Leavitt Equity Partners Ii, Llc	10 percent owner	299 SOUTH MAIN STREET SUITE 2300, SALT LAKE CITY UT 84111
Lep Management Llc	10 percent owner	299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111
Taylor S. Leavitt	10 percent owner	299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111
Leavitt Equity Partners Iii, L.p.	10 percent owner, other: See Remarks	299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111
Leavitt Equity Partners Iii, Llc	10 percent owner, other: See Remarks	299 SOUTH MAIN STREET, SUITE 2300, SALT LAKE CITY UT 84111
Cpf Iii-a Pt Spv, Llc	10 percent owner	980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611
Cpf Iii Pt Spv, Llc	10 percent owner	980 NORTH MICHIGAN AVENUE, SUITE 1998, CHICAGO IL 60611
Erin Darakjian	officer: Interim CFO, Senior VP & CAO	C/O P3 HEALTH PARTNERS INC., 2370 CORPORATE CIRCLE, SUITE 300, HENDERSON NV 89074